Larimar Therapeutics Inc (NASDAQ: LRMR) is -50.65% lower on its value in year-to-date trading and has touched a low of $1.61 and a high of $11.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LRMR stock was last observed hovering at around $1.84 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $1.91, the stock is -6.76% and -26.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.09 million and changing 3.80% at the moment leaves the stock -66.58% off its SMA200. LRMR registered -73.62% loss for a year compared to 6-month loss of -74.26%. The firm has a 50-day simple moving average (SMA 50) of $2.6084 and a 200-day simple moving average (SMA200) of $5.714425.
The stock witnessed a -25.68% gain in the last 1 month and extending the period to 3 months gives it a -41.23%, and is 7.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.55% over the week and 9.02% over the month.
Larimar Therapeutics Inc (LRMR) has around 65 employees, a market worth around $122.29M and $0.00M in sales. Distance from 52-week low is 18.63% and -82.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.83%).
The EPS is expected to shrink by -38.94% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Larimar Therapeutics Inc (LRMR) Top Institutional Holders
152.0 institutions hold shares in Larimar Therapeutics Inc (LRMR), with institutional investors hold 112.40% of the company’s shares. The shares outstanding are 63.82M, and float is at 36.59M with Short Float at 13.16%. Institutions hold 110.80% of the Float.
The top institutional shareholder in the company is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with over 21.23 million shares valued at $153.93 million. The investor’s holdings represent 33.278% of the LRMR Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 6.05 million shares valued at $43.83 million to account for 9.4752 of the shares outstanding. The other top investors are JANUS HENDERSON GROUP PLC which holds 4.38 million shares representing 6.8609% and valued at over $31.63 million, while GOLDMAN SACHS GROUP INC holds 6.791 of the shares totaling 4.33 million with a market value of $31.41 million.
Larimar Therapeutics Inc (LRMR) Insider Activity
#####
